(Q36791061)

16 August 2017

1 reference

title

Onychomycosis in the elderly : drug treatment options (English)

1 reference

16 August 2017

Daniel S Loo

1

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

24

1 reference

16 August 2017

4

1 reference

16 August 2017

293-302

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200724040-00003

16 August 2017

0 references

cites work

Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.

1 reference

12 December 2020

Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly

1 reference

12 December 2020

Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach

1 reference

12 December 2020

A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region

1 reference

12 December 2020

Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients

1 reference

12 December 2020

Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study.

1 reference

12 December 2020

Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey.

1 reference

12 December 2020

Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients

1 reference

12 December 2020

Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis

1 reference

12 December 2020

How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data

1 reference

12 December 2020

Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly

1 reference

12 December 2020

Long-term post-treatment follow-up of onychomycosis treated with terbinafine: a multicentre trial

1 reference

12 December 2020

1 reference

12 December 2020

Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature

1 reference

12 December 2020

Successful treatment of toenail mycosis with terbinafine and itraconazole gives long term benefits

1 reference

12 December 2020

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail

1 reference

12 December 2020

Cost-effectiveness of diagnostic tests for toenail onychomycosis: a repeated-measure, single-blinded, cross-sectional evaluation of 7 diagnostic tests

1 reference

12 December 2020

Epidemiology, clinical presentation and diagnosis of onychomycosis

1 reference

12 December 2020

Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients

1 reference

12 December 2020

Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial

1 reference

12 December 2020

Onychomycosis in clinical practice: factors contributing to recurrence

1 reference

12 December 2020

Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis

1 reference

12 December 2020

Long-term efficacy of antifungals in toenail onychomycosis: a critical review

1 reference

12 December 2020

Candida infection of the nail: role of Candida as a primary or secondary pathogen

1 reference

12 December 2020

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis

1 reference

12 December 2020

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

1 reference

12 December 2020

1 reference

12 December 2020

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study

1 reference

12 December 2020

Retrospective study of onychomycosis in Italy: 1985-2000

1 reference

12 December 2020

Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients

1 reference

12 December 2020

Factors that may affect the response of onychomycosis to oral antifungal therapy

1 reference

12 December 2020

Open label trial of the efficacy and tolerability of Lamisil (Terbinafine) 500 mg once daily in the treatment of onychomycosis due to candida

1 reference

12 December 2020

Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.

1 reference

12 December 2020

Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.

1 reference

12 December 2020

Itraconazole pulse therapy for the treatment of Candida onychomycosis

1 reference

12 December 2020

Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly

1 reference

12 December 2020

Nail changes and disorders among the elderly

1 reference

12 December 2020

Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis

1 reference

12 December 2020

Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002.

1 reference

12 December 2020

Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.

1 reference

12 December 2020

Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases

1 reference

12 December 2020

Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy

1 reference

12 December 2020

Treatment of Candida nail infection with terbinafine

1 reference

12 December 2020

10.2165/00002512-200724040-00003

Identifiers

DOI

1 reference

PubMed ID

17432924

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17432924